Product

Introducing BlueCheck™

Caries detection and monitoring

Incisive Technologies’ first product, is a device which aids dental professionals in the visualisation dental decay.

Dental caries (tooth decay) is the most prevalent chronic disease worldwide, yet it is preventable. It progresses over time and affects individuals throughout their lives. The challenge is that early warning signs—early caries lesions—are not clearly visible, so they often go undetected. However, the ability to halt or even reverse disease is greatest at these earliest stages.

BlueCheck helps clinicians simplify the management of their patients’ oral health by taking the guesswork out of early caries detection.

Porosity is a biomarker of dental decay. Using the natural chemistry of proteins, BlueCheck has an affinity for porous enamel (hydroxyapatite). It reveals porosity with a blue colour at active sites, making hidden disease visible and easier to identify. Healthy enamel and arrested (healed) lesions do not turn blue. As an objective measure, BlueCheck enhances patient education and supports acceptance of the recommended treatment plan.

With earlier diagnosis, drill‑free prevention options can be initiated sooner, enamel damage can be prevented or reversed, and patient outcomes are improved.

BlueCheck is US FDA‑cleared and available for use by dental professionals across the United States. It is intended to provide objective evidence of demineralised areas (caries lesions) and their activity status to aid clinicians during routine examination as part of diagnosis, treatment planning, and ongoing monitoring.

Learn more

US Orders here

Publications

  • Mangum J, et al. Surface Integrity Governs the Proteome of Hypomineralized Enamel. J Dent Res 89 (10):1160-1065, 2010.

  • Jablonski-Momeni A, et al. Ability of BlueCheck liquid stain as a novel technology to detect initial enamel demineralization. Car Res 2022; 56:555-565.

  • Lippert F, et al. Detection of Artificial Enamel Caries-like Lesions with a Blue Hydroxyapatite-Binding Porosity Probe. J of Dent, 135, 2023 104601.

  • White J, et al. Assessment of two methods for detecting carious dentin: an in vitro study. BMC Oral Health 25, 258 (2025). 

  • White J, et al. Assessment of two novel methods for detecting non-cavitated, smooth surface enamel lesions: an in vitro study. BMC Oral Health 25, 843 (2025). 

  • Jablonski-Momeni A, et al. Ability of BlueCheck Liquid for Detection of Initial Lesions on Occlusal Surfaces In Vitro. Diagnostics. 2025; 15(24):3145.

  • Poster: Mascarenhas R, et al. Investigation of a novel diagnostic for early detection of white spot lesions. ASO, March 2022.

  • Poster: Lippert F, et al. Investigating the ability of a blue dye to selectively stain early enamel caries lesions. ORCA, July 2022.

  • Poster: Jablonski-Momeni A, et al. In-vitro performance of BlueCheck liquid as a novel technology for detection of initial enamel demineralization. ORCA, July 2022.

  • Poster: Jablonski-Momeni A, et al. In-vitro performance of BlueCheck liquid for detection of initial lesions on occlusal surfaces. ORCA, July 2023.

  • Poster: Mangum J, et al. BlueCheck: A hydroxyapatite-binding porosity probe for sensitive detection of carious lesions. IADR, March 2024.

  • Poster: Dai R, et al. Detecting Initial Enamel Caries in Orthodontic Patients with BlueCheck. A Pilot Study. ASO, March 2024. 

  • Poster: Jablonski-Momeni A, et al. A new early caries detection aid (BlueCheck) does not inhibit remineralisation of artificial enamel caries. ORCA, June 2024. 

  • Poster: Kukreti P, et al. Usability Evaluation of a Novel Tooth Decay Indicator. AADOCR, March 2025.

  • Poster: Hegarty K et al. Comparative evaluation of Techniques for detecting early occlusal carious lesions. AAC, September 2025.